TdT anticorps
Aperçu rapide pour TdT anticorps (ABIN1112828)
Antigène
Voir toutes TdT (DNTT) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Immunogène
- A synthetic peptide (conjugated with KLH) corresponding to the C-terminal of human TDT.
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- WB (1:1000). Other applications have not been tested. The optimal dilutions should be determined by end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- TBS (pH7.4), 0.5% BSA, 25% Glycerol and 0.05% Sodium Azide.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C after thawing (1 week). Aliquot and store at -20 °C for long term (at least one year). Avoid repeated freeze and thaw cycles.
-
Date de péremption
- 12 months
-
-
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
-
Autre désignation
- Terminal deoxynucleotidyl transferase, TDT
-
Sujet
- Terminal deoxynucleotidyl transferase (TdT), also known as DNA nucleotidylexotransferase (DNTT) or terminal transferase, is a DNA polymerase expressed in immature lymphocytes of the thymus and bone marrow, as well as certain leukemic cells. 1 TDT cDNA contains an open reading frame of 1530 base pairs (bp) corresponding to a protein containing 510 amino acids. 2 TDT is a useful marker in the diagnosis of acute lymphoblastic leukemia (ALL) (French-American-British [FAB] L1 and L2) and is most useful in distinguishing ALL from mature B-lymphoid neoplasms, such as Burkitt lymphoma (FAB L3) and other lymphoid malignancies. 3
-
Pathways
- Réparation de l'ADN
Antigène
-